Consensus-based algorithms to address opioid misuse behaviors among individuals prescribed long-term opioid therapy: developing implementation strategies and pilot testing

基于共识的算法,用于解决接受长期阿片类药物治疗的个体中阿片类药物滥用行为:制定实施策略和试点测试

基本信息

项目摘要

Project Summary: Despite a growing understanding of the risks of long-term opioid therapy (LTOT), it contin- ues to be frequently prescribed and remains a mainstay of treatment for chronic pain. The CDC Guideline for Prescribing Opioids for Chronic Pain is geared toward primary care providers and has been adopted as the standard of care by many healthcare organizations and insurers. Importantly, it encourages monitoring of pa- tients on LTOT for opioid-related harms. By implementing monitoring, primary care providers may uncover var- ious concerning behaviors, sometimes called aberrant drug-related behaviors or opioid misuse behaviors, that arise among individuals prescribed LTOT for chronic pain. These behaviors (e.g., missed appointments, using more opioid medication than prescribed, asking for an increase in opioid dose, aggressive behavior, and alco- hol and other substance use) are common, concerning, and may represent unsafe use of LTOT or a develop- ing opioid use disorder (OUD). However, the CDC Guideline and other existing evidence do not provide specif- ic, detailed guidance about how to address concerning behaviors when they occur. Therefore, there is a critical need to understand how to best respond to these behaviors. The long-term goal of our program of research is to reduce LTOT-related harms, particularly from opioid misuse, and diminish their impact on the U.S. opioid epidemic. As a first step toward accomplishing this goal, we conducted a Delphi study to rigorously establish consensus-based approaches to managing common and challenging concerning behaviors, from which we created algorithms. Identifying and operationalizing implementation strategies using an evidence-based framework are the critical next steps that must occur before any testing of the algorithms. Therefore, we will pursue the following Specific Aims: Aim 1: To a) identify and b) operationalize implementation strategies for the algorithms. Our approach will be guided by the Consolidated Framework for Implementation Research (CFIR) and the Expert Recommendations for Implementing Change (ERIC). Optimal implementation strategies will be uncovered through primary care provider experiences with Standardized Patients (SPs) followed by CFIR- and ERIC-guided group interviews. Using our prior expertise developing clinic-wide opioid risk reduction strategies and a Patient-Provider advisory board, we will develop a comprehensive “implementation package” that can be delivered to primary care practices. Aim 2: To conduct a pilot trial of the algorithms. Guided by the CFIR-based implementation plan and using the implementation package developed in Aim 1b, we will con- duct a pilot trial to investigate the algorithms’ feasibility, acceptability, and preliminary effectiveness. This ap- proach is innovative because it involves novel algorithms and uses SPs in a new way, to identify and opera- tionalize implementation strategies. The proposed research is significant because it will lead to an R01 to eval- uate the algorithms and implementation strategies in an effectiveness-implementation type 2 hybrid trial that, if successful, would reduce opioid misuse-related harms and diminish their impact on the opioid epidemic.
项目摘要:尽管人们越来越了解长期阿片类药物治疗 (LTOT) 的风险,但它仍然存在 经常被开出处方,并且仍然是治疗慢性疼痛的主要方法。 为慢性疼痛开阿片类药物是针对初级保健提供者,并已被采用为 重要的是,它鼓励对患者进行监控。 通过实施监测,初级保健提供者可能会发现因阿片类药物相关危害而接受 LTOT 的患者。 令人担忧的行为,有时称为异常药物相关行为或阿片类药物滥用行为, 这些行为(例如,错过预约、使用 LTOT 治疗慢性疼痛)中出现。 比处方更多的阿片类药物、要求增加阿片类药物剂量、攻击性行为和酒精 hol 和其他物质的使用)是常见的、令人担忧的,并且可能代表 LTOT 或开发中的不安全使用 然而,CDC 指南和其他现有证据并未提供具体信息。 因此,有一个关键的指导,说明如何在发生相关行为时进行处理。 我们研究计划的长期目标是了解如何最好地应对这些行为。 减少 LTOT 相关危害,特别是阿片类药物滥用造成的危害,并减少其对美国阿片类药物的影响 作为实现这一目标的第一步,我们进行了德尔菲研究来严格建立。 基于共识的方法来管理常见和具有挑战性的行为,从中我们 使用基于证据的算法来识别和实施实施策略。 框架是对算法进行任何测试之前必须执行的关键后续步骤。 追求以下具体目标: 目标 1:a) 确定和 b) 实施实施战略 我们的方法将以实施研究综合框架为指导。 (CFIR) 和实施变革的专家建议 (ERIC)。 将通过初级保健提供者与标准化患者 (SP) 的经验来发现,然后 CFIR 和 ERIC 指导的小组访谈利用我们先前的专业知识开发诊所范围内的阿片类药物风险降低。 战略和患者提供者咨询委员会,我们将制定全面的“实施方案” 目标 2:对算法进行试点试验。 基于 CFIR 的计划实施并使用目标 1b 中开发的实施包,我们将继续 进行试点,研究算法的可行性、可接受性和初步有效性。 proach 是创新的,因为它涉及新颖的算法并以新的方式使用 SP 来识别和操作 拟议的研究意义重大,因为它将导致 R01 评估- 在有效性实施类型 2 混合试验中使用算法和策略实施,如果 如果成功,将减少阿片类药物滥用相关的危害并减少其对阿片类药物流行的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jessica S Merlin其他文献

Benefits, Harms, and Stakeholder Perspectives Regarding Opioid Therapy for Pain in Individuals With Metastatic Cancer: Protocol for a Descriptive Cohort Study
关于阿片类药物治疗转移性癌症患者疼痛的益处、危害和利益相关者观点:描述性队列研究方案
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    1.7
  • 作者:
    K. Jones;Gretchen E White;Antonia Bennett;H. Bulls;Paula Escott;Sarah Orris;Elizabeth Escott;Stacy M Fischer;Megan E. Hamm;T. Krishnamurti;Risa L Wong;Thomas W. LeBlanc;Jane Liebschutz;S. Meghani;Cardinale B Smith;Jennifer Temel;Christine S Ritchie;Jessica S Merlin
  • 通讯作者:
    Jessica S Merlin
Nicotine Metabolite Ratio Decreases After Switching Off Efavirenz‐Based Therapy in People With HIV Who Smoke
吸烟的艾滋病毒感染者停止依非韦伦治疗后尼古丁代谢率下降
  • DOI:
    10.1002/cpt.3068
  • 发表时间:
    2023-10-03
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Dominique Medaglio;Warren B. Bilker;Xiaoyan Han;Jessica S Merlin;Michael Plankey;Jeffrey Martin;Heidi M Crane;Leila S. Hojat;Laura Bamford;R. Schnoll;R. Tyndale;R. Ashare;Robert Gross
  • 通讯作者:
    Robert Gross
An Observational Study of Dialogue about Uncertainty in Clinician-Family Counseling Conversations Following Prenatal Diagnosis of Complex Congenital Heart Disease
复杂先天性心脏病产前诊断后临床医生与家庭咨询对话中不确定性的观察研究
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kelly W. Harris;Kelsey Schweiberger;Ann Kavanaugh;Robert M. Arnold;Jessica S Merlin;Judy C. Chang;N. A. Kasparian
  • 通讯作者:
    N. A. Kasparian

Jessica S Merlin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jessica S Merlin', 18)}}的其他基金

Mentoring the next generation of researchers at the intersection of opioid use disorder and chronic pain
指导下一代研究人员研究阿片类药物使用障碍和慢性疼痛的交叉点
  • 批准号:
    10663642
  • 财政年份:
    2023
  • 资助金额:
    $ 23.48万
  • 项目类别:
Mentoring the next generation of researchers at the intersection of opioid use disorder and chronic pain
指导下一代研究人员研究阿片类药物使用障碍和慢性疼痛的交叉点
  • 批准号:
    10663642
  • 财政年份:
    2023
  • 资助金额:
    $ 23.48万
  • 项目类别:
Opioid therapy for pain in individuals with metastatic cancer: benefits, harms and stakeholder perspectives
阿片类药物治疗转移性癌症患者的疼痛:益处、危害和利益相关者的观点
  • 批准号:
    10670405
  • 财政年份:
    2021
  • 资助金额:
    $ 23.48万
  • 项目类别:
Opioid therapy for pain in individuals with metastatic cancer: benefits, harms and stakeholder perspectives
阿片类药物治疗转移性癌症患者的疼痛:益处、危害和利益相关者的观点
  • 批准号:
    10280057
  • 财政年份:
    2021
  • 资助金额:
    $ 23.48万
  • 项目类别:
Consensus-based algorithms to address opioid misuse behaviors among individuals prescribed long-term opioid therapy: developing implementation strategies and pilot testing
基于共识的算法,用于解决接受长期阿片类药物治疗的个体中阿片类药物滥用行为:制定实施策略和试点测试
  • 批准号:
    10055996
  • 财政年份:
    2020
  • 资助金额:
    $ 23.48万
  • 项目类别:
Consensus-based algorithms to address opioid misuse behaviors among individuals prescribed long-term opioid therapy: developing implementation strategies and pilot testing
基于共识的算法,用于解决接受长期阿片类药物治疗的个体中阿片类药物滥用行为:制定实施策略和试点测试
  • 批准号:
    10405067
  • 财政年份:
    2020
  • 资助金额:
    $ 23.48万
  • 项目类别:
Evaluation of the efficacy and mechanisms of a novel intervention for chronic pain tailored to people living with HIV
评估针对艾滋病毒感染者量身定制的慢性疼痛新型干预措施的功效和机制
  • 批准号:
    9922384
  • 财政年份:
    2018
  • 资助金额:
    $ 23.48万
  • 项目类别:
Evaluation of the efficacy and mechanisms of a novel intervention for chronic pain tailored to people living with HIV
评估针对艾滋病毒感染者量身定制的慢性疼痛新型干预措施的功效和机制
  • 批准号:
    10397398
  • 财政年份:
    2018
  • 资助金额:
    $ 23.48万
  • 项目类别:
Development of a Behavioral Intervention for Chronic Pain in Individuals with HIV
开发针对艾滋病毒感染者慢性疼痛的行为干预措施
  • 批准号:
    9180066
  • 财政年份:
    2014
  • 资助金额:
    $ 23.48万
  • 项目类别:

相似国自然基金

血管内皮细胞通过E2F1/NF-kB/IL-6轴调控巨噬细胞活化在眼眶静脉畸形中的作用及机制研究
  • 批准号:
    82301257
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
睡眠剥夺通过上调BMAL1/IL-17轴促进三级淋巴结构形成加重哮喘的研究
  • 批准号:
    82300039
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
S100A6通过调控ZNF750组蛋白甲基化促进糖尿病角质形成细胞分化障碍的机制研究
  • 批准号:
    82302802
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肿瘤相关成纤维细胞通过CCL5/CCR5轴促进神经内分泌前列腺癌顺铂耐药的机制研究
  • 批准号:
    82373358
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
鼻腔共生表皮葡萄球菌通过抗菌肽-moDC-CCL17通路抑制过敏性鼻炎的分子机制
  • 批准号:
    82302595
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Proactive Management to Improve Laboratory Macaque Breeding Colony Health and Well-being
积极管理以改善实验室猕猴繁育群体的健康和福祉
  • 批准号:
    10090056
  • 财政年份:
    2021
  • 资助金额:
    $ 23.48万
  • 项目类别:
Proactive Management to Improve Laboratory Macaque Breeding Colony Health and Well-being
积极管理以改善实验室猕猴繁育群体的健康和福祉
  • 批准号:
    10676981
  • 财政年份:
    2021
  • 资助金额:
    $ 23.48万
  • 项目类别:
Proactive Management to Improve Laboratory Macaque Breeding Colony Health and Well-being
积极管理以改善实验室猕猴繁育群体的健康和福祉
  • 批准号:
    10090056
  • 财政年份:
    2021
  • 资助金额:
    $ 23.48万
  • 项目类别:
Proactive Management to Improve Laboratory Macaque Breeding Colony Health and Well-being
积极管理以改善实验室猕猴繁育群体的健康和福祉
  • 批准号:
    10676981
  • 财政年份:
    2021
  • 资助金额:
    $ 23.48万
  • 项目类别:
Proactive Management to Improve Laboratory Macaque Breeding Colony Health and Well-being
积极管理以改善实验室猕猴繁育群体的健康和福祉
  • 批准号:
    10417009
  • 财政年份:
    2021
  • 资助金额:
    $ 23.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了